INSULIN-LIKE GROWTH FACTOR-BINDING PROTEINS IN THE HUMAN FETUS - TISSUE-SPECIFIC PROTEIN SECRETION, IMMUNOLOGICAL CHARACTERIZATION, AND GENE-EXPRESSION
Em. Pannier et al., INSULIN-LIKE GROWTH FACTOR-BINDING PROTEINS IN THE HUMAN FETUS - TISSUE-SPECIFIC PROTEIN SECRETION, IMMUNOLOGICAL CHARACTERIZATION, AND GENE-EXPRESSION, American journal of obstetrics and gynecology, 171(3), 1994, pp. 746-752
OBJECTIVES: The objectives of this study were to investigate the profi
le of insulin-like growth factor-binding proteins secreted by human fe
tal tissues and their immunologic identification and tissue-specific g
ene expression. STUDY DESIGN: Explants of midgestational fetal tissues
from seven fetuses were cultured with and without cycloheximide. Cond
itioned media were examined for insulin-like growth factor-binding pro
teins by Western ligand blot analysis, and insulin-like growth factor-
binding proteins were identified by immunoprecipitation. Gene expressi
on was analyzed by Northern analysis. RESULTS: Fetal liver and kidney
explants secreted insulin-like growth factor-binding protein-1 to insu
lin-like growth factor-binding protein-4, with insulin-like growth fac
tor-binding protein-1 being the most prominent in liver. Fetal lung se
creted insulin-like growth factor-binding protein-2 and insulin-like g
rowth factor-binding protein-4 and lesser amounts of insulin-like grow
th factor-binding protein-3, whereas white matter explants secreted ex
clusively insulin-like growth factor-binding protein-2 and insulin-lik
e growth factor-binding protein-4. Cycloheximide inhibited secretion o
f binding proteins, suggesting de novo synthesis. Northern blot analys
es were consistent with the protein studies. CONCLUSION: These data de
monstrate that insulin-like growth factor-binding protein secretion by
fetal tissues is tissue specific.